News | Page 54 | Weill Department of Medicine

Star Performer and Other Outstanding Employees Honored in the DOM

L to R: Dr. Joseph T. Cooke (Chief, Pulmonary & Critical Care Medicine), Malika Maddison (Div. Admin), Yvette Soltren & Darren BirksThe Employee Recognition Review Committee (R3) of the Department of Medicine (DOM) completed its bimonthly review of all nominees. Darren Birks, Medical Secretary (Division of Pulmonary Medicine & Critical Care), was named top "Star Performer" of this cycle. Darren was described as exemplifying "team player" in the office, and a patient stated: "He took... Read More

Dr. Béguelin Presents Abstract at ASH Meeting: One of Six Papers Selected from 6,000

Dr. Wendy BeguelinIt was more good news for the Melnick Lab, internationally recognized for its work on cancer and epigenetics, when Wendy Béguelin, Ph.D. learned that her project abstract had been selected for presentation at the plenary session of the 55th Annual Meeting of the American Society of Hematology (ASH) being held this weekend in New Orleans, LA. The President of ASH, Janis L. Abkowitz, M.D., informed Dr. Béguelin, who is a Revson Fellow working on lymphoma research, that her paper... Read More

Dr. Bykerk Presents New Research on Arthritis at ACR/ARHP Annual Meeting

Dr. Vivian BykerkDr. Vivian Bykerk, on staff at the Hospital for Special Surgery (HSS) and an Associate Professor of Medicine (Department of Medicine) at Weill Cornell, presented advances in arthritis research at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professions. As a lead investigator and rheumatologist at HSS, she conducted a study on rheumatoid arthritis (RA) that utilized data from the Canadian early ArThritis Cohort (CATCH), for which... Read More

Hepatitis C Public Outreach Effort and Good News Too: Dr. de Jong Interviewed on NY1

Dr. Ype de JongDr. Ype de Jong, Assistant Professor of Medicine (Division of Gastroenterology & Hepatology), was interviewed on NY1 regarding recent public outreach about hepatitis C in New York. He also spoke about the rapidly evolving management of this serious disease that infects the liver through blood products, and which can cause cirrhosis and liver cancer.Last year, 750 city residents died from hepatitis C. Deputy City Health Commissioner, Dr. Jay Varma, has projected that the city... Read More

Outstanding Employees Honored in the DOM

The Employee Recognition Review Committee (R3) of the Department of Medicine (DOM) completed its bimonthly review of all nominees. The program, honoring outstanding service by DOM employees, named Margie Daly, Residency Program Manager, Division of Education, as the top "Star Performer" of this cycle. Known for her compassion and generosity of spirit in dealing with house staff and colleagues alike, Margie never hesitates to assume new responsibilities while maintaining stability and... Read More

Dr. Etingin Receives Maurice R. Greenberg Distinguished Service Award

Dr. Orli EtinginOn May 30, 2013, Dr. Orli Etingin received the prestigious Maurice R. Greenberg Distinguished Service Award at a celebration held at The Plaza Hotel in Manhattan. Established in 1980, the award recognizes exceptional and longstanding service demonstrated by a senior member of the medical staff.Dr. Etingin began her clinical practice at NewYork-Presbyterian/Weill Cornell in 1994 in general internal medicine and hematology-oncology. She founded the Iris Cantor Women's Health... Read More

A Champion of Diversity: Dr. Susana Morales Receives Excellence in Mentorship Award

Dr. Susana MoralesDr. Susana Morales, a longtime champion of diversity at NewYork-Presbyterian/Weill Cornell, received the coveted Bruce Laine Ballard, M.D. Faculty Award for Excellence in Mentorship. This honor is one of the Pioneer in Diversity Awards given by The Office of Faculty Diversity in Medicine and Science highlighting faculty who have distinguished themselves as key contributors to the culture of diversity."There's no greater honor than being recognized by people you have helped... Read More

Dr. Melnick and Team Publish Pivotal Paper in Cell Reports: Stage Set for Clinical Trials Using Experimental New Drug for Lymphoma (DLBCL)

On the heels of numerous advancements by the Melnick Lab, the latest breakthrough involves an experimental new drug that is capable of completely eradicating human lymphoma in mice after five doses. Published in Cell Reports (August 2013), this finding sets the stage for clinical trials that would use an experimental drug for the treatment of B-cell lymphoma (DLBCL). Dr. Ari Melnick, who joined the Division of Hematology and Medical Oncology in 2008, established that Bcl6 is a master regulatory... Read More

Weill Cornell Community Clinic (WCCC) Welcomes Dr. Pamela Charney as Medical Director

Dr. Pamela CharneyRecognized for her ongoing service in community-based medicine, Dr. Charney has joined the WCCC as its new clinical director. In this role, she will work extensively with the student clinical directors of this Weill Cornell student-based initiative that operates out of WCIMA and provides valuable patient care to individuals who are under- or uninsured. Dr. Charney is a Professor of Clinical Medicine at Weill Cornell and an Attending Physician at NewYork-Presbyterian Hospital.... Read More

Dr. Roboz Leads New Trials for MDS: First-Time Use of AQD Drug for MDS in a Clinical Trial

Dr. Gail RobozDr. Gail Roboz, Associate Professor of Medicine and Director of the Leukemia Program at NYP/WC, has been named lead investigator for a Sunesis Pharmaceuticals-funded clinical trial for the treatment of myelodysplastic syndrome (MDS). A Phase I/II (open-label, dose escalating) trial, it is set to enroll approximately 40 patients with MDS who previously experienced failed treatment using hypomethylating agent-based therapy. Using an AQD (anti-cancer quinolone derivative) drug (... Read More